Mary Vaughan Sarrazin

Has grant

Country flagUnited States

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Dosing of Direct Oral Anticoagulants for stroke prevention in Atrial Fibrillation: Patterns, Consequences, and Guidance

Open Date: 2017-09-15

Close Date: 2020-04-30

Grant: Close

Stroke Prevention for Atrial Fibrillation with Multiple Chronic Conditions

Open Date: 2014-09-01

Close Date: 2017-02-28

Grant: Close

Comparative effectiveness of dabigatran and warfarin for stroke prevention in atr

Open Date: 2012-09-06

Close Date: 2014-08-31

Grant: Close

Impact of Certificate of Need on the Use of Revascularization for AMI

Open Date: 2006-06-01

Close Date: 2008-05-31

Grant: Close

The significance of racial segregation for CV disease

Open Date: 2006-03-01

Close Date: 2009-02-28

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Objective Rural veterans have high obesity rates. Yet, little is known about this population's engagement with the Veterans Affairs (VA) weight management program (MOVE!). The study objective is to determine whether MOVE! enrollment, anti‐obesity medication use, bariatric surgery use, retention, and outcomes differ by rurality for veterans with severe obesity. Methods This is a retrospective cohort study using Veterans Health Administration patient databases, including VA patients with severe obesity during 2015–2017. Patients were categorized using Rural‐Urban Commuting Area codes. Primary outcomes included proportion of patients and risk‐adjusted likelihood of initiating VA MOVE!, anti‐obesity medication, or bariatric surgery and risk‐adjusted highly rural|Hazard Ratio (HR) of any obesity treatment. Secondary outcomes included treatment retention (≥12 weeks) and successful weight loss (5%) among patients initiating MOVE!, and risk‐adjusted odds of retention and successful weight loss. Results Among 640,555 eligible veterans, risk‐adjusted relative likelihood of MOVE! treatment was significantly lower for rural and HR veterans (HR = 0.83, HR = 0.67, respectively). Initiation rates of anti‐obesity medication use were significantly lower as well, whereas bariatric surgery rates, retention, and successful weight loss did not differ. Conclusions Overall treatment rates with MOVE!, bariatric surgery, and anti‐obesity medications remain low. Rural veterans are less likely to enroll in MOVE! and less likely to receive anti‐obesity medications than urban veterans.

Year:

2022

Collaborators (13)

Neil Keshvani

University of Texas Southwestern Medical Center

UNITED STATES
View details

Benjamin Griffin

Assistant Professor

Iowa State University

UNITED STATES
View details

Marwan Saad

Brown University Warren Alpert Medical School

UNITED STATES
View details

Dharam J. Kumbhani

-

UNITED STATES
View details

Shipra Arya

Stanford University School of Medicine

UNITED STATES
View details

Daniel Livorsi

The University of Iowa Roy J and Lucille A Carver College of Medicine

UNITED STATES
View details

Saket Girotra

Associate Professor

University of Texas Southwestern Medical Center

UNITED STATES
View details

Rolando Sanchez

Associate professor, clinician educator track

Iowa State University

UNITED STATES
View details

Michael Matheny

Associate Professor

Vanderbilt University Medical Center

UNITED STATES
View details

Sharidan Parr

Vanderbilt University Medical Center

UNITED STATES
View details

Olga V Patterson

University of Utah

UNITED STATES
View details

Nihar R. Desai

-

UNITED STATES
View details

Michihiko Goto

Associate Professor

The University of Iowa Roy J and Lucille A Carver College of Medicine

UNITED STATES
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.